21st.BIO Competitors and Similar CompaniesClear all

21st.BIO's competitors and similar companies include Centogene and Codexis.

	21st.BIO 21st.BIO is a bioproduction company focused on the production optimization of proteins and peptides for the food, materials, and agricultural industries.	Centogene Centogene is a biotechnology company that provides services in the field of genetic diagnostics for rare hereditary diseases.	Codexis Codexis is a protein engineering company that develops enzymes for pharmaceutical, food, and medical applications.
Founding Date	Founding Date 2020	Founding Date 2005	Founding Date 2002
Type	Type Private	Type Public	Type Public
Tags	Tags Technology bioengineering biotech platform	Tags Technology bioengineering biotech genetics medical diagnostics platform	Tags Technology bioengineering biotech pharma platform
Locations	Locations Virum, DK HQ	Locations Rostock, DE HQ Wien, AT Berlin, DE Frankfurt Am Main, DE Hamburg, DE Greater Noida, IN Dubai, AE see more	Locations Redwood City, US HQ
Employees	Employees 635% increase	Employees 80823% increase	Employees 1888% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 9.4 m	Valuation ($) 226.3 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €48.5m (FY, 2023)	Revenue (est.) $70.4m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods €29.1m (FY, 2023)	Cost of goods $9.3m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit €23.7m (FY, 2023)	Gross profit $61m (FY, 2025)
Net income	Net income N/A	Net income (€35.5m) (FY, 2023)	Net income ($44m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 97.1m	Total funding raised $ 29.6m	Total funding raised $ 87m